CN101603010B - Fast cultivation method for Taisui - Google Patents
Fast cultivation method for Taisui Download PDFInfo
- Publication number
- CN101603010B CN101603010B CN2009100653492A CN200910065349A CN101603010B CN 101603010 B CN101603010 B CN 101603010B CN 2009100653492 A CN2009100653492 A CN 2009100653492A CN 200910065349 A CN200910065349 A CN 200910065349A CN 101603010 B CN101603010 B CN 101603010B
- Authority
- CN
- China
- Prior art keywords
- taisui
- honey
- ganoderma
- parts
- cultivation method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012364 cultivation method Methods 0.000 title claims abstract description 18
- 235000012907 honey Nutrition 0.000 claims abstract description 68
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 63
- 239000011707 mineral Substances 0.000 claims abstract description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- 235000015097 nutrients Nutrition 0.000 claims abstract description 32
- 241001165494 Rhodiola Species 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 241000804384 Cynomorium songaricum Species 0.000 claims abstract description 16
- 241001412627 Adenophora liliifolia Species 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 241000222336 Ganoderma Species 0.000 claims description 72
- 238000004140 cleaning Methods 0.000 claims description 12
- 230000000050 nutritive effect Effects 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 239000003643 water by type Substances 0.000 claims description 11
- 244000241838 Lycium barbarum Species 0.000 claims description 10
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 10
- 239000000835 fiber Substances 0.000 claims description 10
- 241000545442 Radix Species 0.000 claims description 7
- 241000005787 Cistanche Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000002023 wood Substances 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 2
- 238000000247 postprecipitation Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 29
- 239000000463 material Substances 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 13
- 230000036541 health Effects 0.000 abstract description 6
- 239000002932 luster Substances 0.000 abstract description 2
- 239000001963 growth medium Substances 0.000 abstract 4
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000336315 Cistanche salsa Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract 1
- 241000210110 Potentilla argentea Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000012136 culture method Methods 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 description 51
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 239000011573 trace mineral Substances 0.000 description 14
- 235000013619 trace mineral Nutrition 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- 239000009636 Huang Qi Substances 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 239000002689 soil Substances 0.000 description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000011701 zinc Substances 0.000 description 8
- 229910052725 zinc Inorganic materials 0.000 description 8
- 230000012010 growth Effects 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 6
- 229910052802 copper Inorganic materials 0.000 description 6
- 239000010949 copper Substances 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- 229910052711 selenium Inorganic materials 0.000 description 6
- 208000019838 Blood disease Diseases 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 208000014951 hematologic disease Diseases 0.000 description 5
- 208000018706 hematopoietic system disease Diseases 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 201000001881 impotence Diseases 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- RUDVAOJNIYYYCQ-HUIKYQPJSA-N (1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosane-7,16-diol Chemical compound CC(C)=C[C@H]1C[C@](C)(O)[C@@H]2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@@]33CO[C@@]2(C3)O1 RUDVAOJNIYYYCQ-HUIKYQPJSA-N 0.000 description 2
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000008445 altitude sickness Diseases 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- -1 glucide Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- RUDVAOJNIYYYCQ-UHFFFAOYSA-N jujubogenin Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)(O)CC(C=C(C)C)OC33OCC21C3 RUDVAOJNIYYYCQ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000004223 radioprotective effect Effects 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000004330 tyrosol Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical group C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 206010034944 Photokeratitis Diseases 0.000 description 1
- WMHJCSAICLADIN-MVVLZTAMSA-N Picrocrocin Natural products O=CC=1C(C)(C)C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)CC=1C WMHJCSAICLADIN-MVVLZTAMSA-N 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- WMHJCSAICLADIN-WYWSWGBSSA-N picrocrocin Chemical compound C1C(C)=C(C=O)C(C)(C)C[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WMHJCSAICLADIN-WYWSWGBSSA-N 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a fast cultivation method for Taisui, and relates to a Taisui strain cultivation technique and a Taisui health product. A culture medium is made from the following raw materials: mineral water, honey, rhodiola, cordyceps sinensis, astragalus roots, snow lotuses, saffron, cynomorium songaricum, cistanche salsa, potentilla anserine and straight ladybell roots. When the culture medium is made, all materials except honey are cleaned, aired, ground, soaked in mineral water for 24 to 48 hours, subjected to residue filtration, added with honey and prepared into the Taisui culture medium. The method has the following significant effects that: 1, the Taisui is fast to cultivate and can grow by over 1 to 1.5 times in a month; 2, the Taisui is good in color and luster, red, bright and attractive; 3, the Taisui is good in shape and can harden and take shape in a month by the method, while the Taisui cultivated by general culture methods is soft, takes no shape, is layered and needs more than one year to harden; and 4, the Taisui is good in quality, is cultured by adopting nutrient-rich culture medium, and has excellent quality.
Description
Technical field:
The present invention relates to Ganoderma breeding strain technology and Ganoderma healthcare products.
Background technology:
Ganoderma is a kind of paleospecies, and early on the books in the Ancient Chinese doctor nationality, Compendium of Material Medica was once done detailed description to its form, proterties, and it is classified as one of five kinds of glossy ganodermas, appellation " meat sesame ", and think food can " make us making light of one's life by commiting suicide, alive for evermore ".Because the Ganoderma form is strange, trace is magical, thereby has been coverd with the veil of all mysteries.Among the people, it is " local tyrant " for people's honor, and what look is wonder, or keeps someone at a respectful distance, or probably keeps away it.
Along with the reproduction of Ganoderma person's movements and expression, the particularly Chinese Central Television (CCTV) in recent years after carrying out special report at the beginning of 2009, people begin more with the method for modern science to its include composition, using value restudies.Assert that at present Ganoderma is a kind of " large-scale Acarasiales complex body ", the composition novelty is peculiar, dives to contain huge value medical health care.Through check; Ganoderma contains Nucleotide, Yelkin TTS, Regitex FA, BSA, flavones, polysaccharide, gsh, saponin, chitin, unsaturated fatty acids, trace element, amino acid, and the novel substance PQQ (PQQ) that knows little about it of a kind of people.Discover; Ganoderma has and the similar effect of glossy ganoderma; And glossy ganoderma be proved have enhance immunity power, strengthen the macrophage phagocytic ability, the effect of hypotensive and blood sugar, transaminase lowering and SUV, can strengthen coronary artery blood flow, promote the reparation and the regeneration of damaged cell; Can improve the quality of sleep quality; The rising white cell; Prevent arteriosclerosis; Promote amino acid whose absorption; The treatment hemolytic anemia; Remove and regulate interior free yl; Prevent the infringement of alcohol and acetaldehyde to liver; Prevent cataract; The anti-inflammatory anti-inflammatory; The treatment osteoporosis; Clinically more than 20 kind of treatment of diseases such as stomach and intestine, liver, kidney, white blood disease, neurasthenia, chronic bronchitis, asthma, mellitus, hypertension, Intracerebral hemorrhage, heart trouble, coronary heart disease, tumour all there is certain effect.In addition, also have remarkable health care and cosmetology function.
Research to Ganoderma at present still is in the junior stage, and along with the medical science and technology progress, can predict in the near future, will go deep into more the research of Ganoderma, and when the time comes, Ganoderma will be made positive contribution to the raising of level of human health.And the task of top priority is the fast breeding method of a kind of Ganoderma of research, with rescue and expansion Ganoderma resource.Existing Ganoderma method of cultivation thalli growth speed all compares slowly, and thalline increases to be twice needs about time more than 10 months at least, has satisfied not the needs of current and further researchdevelopment far away.
Summary of the invention:
Goal of the invention of the present invention is to provide a kind of fast cultivation method for Taisui, but uses the present invention's quickly breeding Ganoderma, the Ganoderma quality better of cultivation.
The objective of the invention is to realize: scheme one: a kind of fast cultivation method for Taisui through following scheme; The Ganoderma bacterial classification is positioned in the nutrient solution; Nutrient solution places container, it is characterized in that: nutrient solution is to be processed by the raw material of following weight part: 600～950 parts of mineral waters, 6～12 parts of honey; 4～10 parts of Root of Kirilow Rhodiola, 1～7 part of entomophyte; During making, Root of Kirilow Rhodiola, entomophyte are pulverized after cleaning airing, put into mineral water and soaked 24～48 hours, filter residue adds honey again, is the Ganoderma nutrient solution.
Preferable range is: 620～850 parts of mineral waters, 7～11 parts of honey, 5～9 parts of Root of Kirilow Rhodiola, 2～6 parts of entomophyte;
Preferred plan is: 680 parts of mineral waters, 9 parts of honey, 7 parts of Root of Kirilow Rhodiola, 4 parts of entomophyte.
The present invention also can further realize through following scheme:
Scheme two: nutrient solution is to be processed by the raw material of following weight part: 600～950 parts of mineral waters, 6～12 parts of honey, 4～10 parts of Root of Kirilow Rhodiola, 1～7 part of entomophyte, 6～12 parts of the Radixs Astragali, 6～12 parts of Snow Lotus Herb, 4～10 parts of Stigma Crocis; During making, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
Preferable range is: 650～900 parts of mineral waters, 7～11 parts of honey, 5～9 parts of Root of Kirilow Rhodiola, 2～6 parts of entomophyte, 7～11 parts of the Radixs Astragali, 7～11 parts of Snow Lotus Herb, 5～9 parts of Stigma Crocis;
Preferred plan is: 780 parts of mineral waters, 9 parts of honey, 7 parts of Root of Kirilow Rhodiola, 4 parts of entomophyte, 9 parts of the Radixs Astragali, 9 parts of Snow Lotus Herb, 7 parts of Stigma Crocis.
Scheme three: nutrient solution is to be processed by the raw material of following weight part: 600～950 parts of mineral waters, 6～12 parts of honey, 4～10 parts of Root of Kirilow Rhodiola, 1～7 part of entomophyte; 6～12 parts of the Radixs Astragali, 6～12 parts of Snow Lotus Herb, 4～10 parts of Stigma Crocis; 6～12 parts of cynomorium songaricums, 6～12 parts of fern fiber crops, 6～12 parts of the root of straight ladybell; During making, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
Preferable range is: 700～930 parts of mineral waters, 7～11 parts of honey, 5～9 parts of Root of Kirilow Rhodiola, 2～6 parts of entomophyte, 7～11 parts of the Radixs Astragali, 7～11 parts of Snow Lotus Herb, 5～9 parts of Stigma Crocis, 7～11 parts of cynomorium songaricums, 7～11 parts of fern fiber crops, 7～11 parts of the root of straight ladybell;
Preferred plan is: 900 parts of mineral waters, 9 parts of honey, 7 parts of Root of Kirilow Rhodiola, 4 parts of entomophyte, 9 parts of the Radixs Astragali, 9 parts of Snow Lotus Herb, 7 parts of Stigma Crocis, 9 parts of cynomorium songaricums, 9 parts of fern fiber crops, 9 parts of the root of straight ladybell.
In this programme, available Herba Cistanches substitutes cynomorium songaricum, and the component of material is constant.
The making method of the nutrient solution that the present invention proposes also can be carried out certain accommodation, promptly utilizes material provided by the invention to become the Ganoderma nutritive powder to sell; During making; To wear into fine powder except that mineral water, material the honey, and form Ganoderma and cultivate the powder base mateiral; Can sell separately, cooperate with honey, mineral water again during use to form the Ganoderma nutrient solution.
When Ganoderma is cultivated; Bacterial classification is positioned in the nutrient solution; Under the condition of 15～35 degree Celsius (preferred temperature is 20～30 degree Celsius), open cultivation 90～120 days, Ganoderma is able to rapid production on the one hand; Its supernatant forms the Ganoderma nutritive medium on the other hand, and this nutritive medium can supply to drink after simple process.Also can further utilize nutritive medium to process the Ganoderma oral liquid; Take out finished product Ganoderma viable bacteria body (generally should under aseptic condition, carry out); The supernatant of results 90% (also can not take out finished product Ganoderma viable bacteria body and direct method acquisition supernatant) with absorption; After the colloidal mill grinding, obtain supernatant through filtering post precipitation, be the Ganoderma oral liquid.
The material of this Ganoderma oral liquid can also pass through existing milling method, directly processes said other formulation of pharmaceutics, like capsule, powder etc.
Among the present invention, mineral water can be selected the Kun Lun Mountain mineral water for use, specifically selectively locates the big vast mineral water of Qinghai Province's Dulan County promise wood in the Caidamu Basin; Honey can be selected Qaidam matrimony vine honey for use, further is to be located in the big vast matrimony vine honey of Qinghai Province's Dulan County promise wood, the matrimony vine honey that the honeybee when especially matrimony vine is red is brewageed; Root of Kirilow Rhodiola can be selected the Himalaya Root of Kirilow Rhodiola for use, and the Radix Astragali, entomophyte, Stigma Croci, Snow Lotus Herb, cynomorium songaricum, the Radix Astragali, fern fiber crops, the root of straight ladybell, Herba Cistanches are all selected the Qinghai-Tibet Platean material that produces for use.
As everyone knows, as breeding of biomass, except that good bacterial classification, the design of nutrient solution and preparation also are vital.In general, the necessary nutrition of life entity is water, protein, glucide, fat, minerals and vitamins, and Ganoderma is a kind of original basic life entity, and grows in undergroundly, by soil nutrition is provided entirely.The formation that it is reported soil is very complicated, and it is made up of solid phase, liquid and gas three-phase material, and solid matter comprises soil mineral, organic matter and mikrobe etc.Liquid substance mainly refers to soil moisture.Gas is the air that is present in the soil pores.Organic content is very little, and organic content only accounts for 0.5～2.5% of soil dry weight in the topsoil of general arable land.After the contriver had carried out detecting contrast to the soil of Ganoderma growing environment and general soil, decision at first was conceived to Ganoderma the demand analysis of growth water quality and mineral substance is studied.Discover, in water, the Ganoderma growth of can surviving, but poor growth; As select mineral water for use, then the reproduction speed of Ganoderma is obviously accelerated, and shows the obvious demand of Ganoderma to mineral substance; As add the necessary nutrition of some life entities again, like VITAMINs, amino acid, then can further improve the reproduction speed of Ganoderma.Because the Ganoderma bacterial classification that the present invention adopts is the excellent species that is unearthed in Qinghai Province, so emphasis selects identical area, occurring in nature and Ganoderma region of living in, VITAMINs, the higher famous and precious plant of amino acid for use, processes nutrient solution.The present invention cultures practice for a long time through the contriver, and constantly substantial perfect, above prescription is the ideal nutrient solution prescription that the contriver screens from a plurality of schemes.
Above-mentioned prescription has following trophology characteristics: 1, content of mineral substances is abundant.Each material mineral content such as mineral water, honey, entomophyte, Stigma Croci, Root of Kirilow Rhodiola, Snow Lotus Herb, cynomorium songaricum is sufficient, and trace element is complete.2, sugar content is abundant.Honey, entomophyte, the Radix Astragali, the root of straight ladybell, fern fiber crops etc. contain abundant polysaccharide in this prescription, abundant amount, and kind is different.3, amino acid is abundant and comprehensive.Amino acid abundance and A wide selection of colours and designs such as entomophyte, honey, Root of Kirilow Rhodiola, Snow Lotus Herb, the Radix Astragali.4, VITAMINs is abundant.Honey, entomophyte, the Radix Astragali etc. contain a large amount of VITAMINss.More than can satisfy the needs of the quick growth reproduction of Ganoderma.
Except that above trophic function, the present invention also has many biology pharmacological functions.
Among the present invention:
Mineral water; Select the natural snow mountain mineral water in Kun Lun Mountain for use; This water underground cycling time greater than 50 years (and most of on the market mineral waters underground cycling time generally be no more than 10 years), be weakly alkaline (pH value 7.20-7.80), in the ability with body inner acidic toxin; Promote toxin expelling in the body, contain more mineral substance the human body beneficial.Wherein, the strontium that is rich in, potassium, sodium, calcium, magnesium, lithium ion are easily absorbed by the body, and help to prevent hypertension and arteriosclerosis, alleviate cardiovascular and heart disease, and the effect of prevent cancer and delay sanility is arranged; Can improve human body hemopoietic function state, improve immunity function.In addition, the natural snow mountain mineral water in Kun Lun Mountain belongs to small-micelle water, can quicken to get into human body cell and participate in metabolic process, and useful HUMAN HEALTH, alleviating fatigue, quality are that nature is preeminent.
Honey; It is a kind of nutritious natural nourishing food; Wherein contain 10 various trace elements such as organic acid, higher alcohols, colloid, alcohol element, fructose, glucose, glycase, oxydase, reductase enzyme, multiple proteins, 17 seed amino acids, 10 multivitamins, silicon, iron, calcium, copper, manganese, potassium, phosphorus, boron etc., have nourishing, moisturize, the effect of detoxifcation.Generally speaking, honey has following function: can improve the composition of blood, promote heart and brain and vascular function; Liver there is provide protection, can impels liver cell regeneration, the restraining effect certain being formed with of fatty liver; Can regain one's strength of body rapidly, Ginseng Extract builds up one's resistance to disease; Germ-resistant effect is arranged; Can treat the skin damage of moderate, treat scald, skin care and prevent and treat frostbite; Help to improve sleep; Heart trouble, hypertension, tuberculosis, illness in eye, hepatopathy, dysentery, constipation, anaemia, nervous system disorders, gastric duodenal ulcer disease etc. all there is good medical assistance effect.The soil and the atmosphere on every side of honey composition and nectariferous plant growth have very big relation, and difference is bigger between different varieties, and the nectariferous plant kind is different, and from different places, the composition of honey is also different.With the trace element is example, and same kind is 0.02%～1.0% from difference between the honey of different areas, mainly contains silicon, magnesium, phosphorus, manganese, iron, calcium, copper, sodium, potassium, aluminium, boron, chromium, nickel etc.Contain trace elements such as the abundant calcium that surmounts other honey, iron, zinc, copper, selenium, molybdenum in the matrimony vine honey.Adopt Kun Lun Mountain matrimony vine honey among the present invention, draw the elite of matrimony vine, more help to promote the quality of honey.
Root of Kirilow Rhodiola contains salidroside, Jujubogenin tyrosol, 17 seed amino acids of needed by human body, 21 kinds of trace elements such as calcium, iron, zinc, manganese.Be mainly used in anoxia, antifatigue, radioprotective, antiviral, antitumor, anti-ageing, improve aspects such as mental and physical function.Contained salidroside and Jujubogenin tyrosol are to neural system and metabolic dual regulation in the Root of Kirilow Rhodiola; Can expand coronary artery effectively, resisting myocardial ischemia improves myocardial function; It can remove lipid too much in the blood, reduces blood viscosity, microcirculation improvement; Can improve the blood circulation of cerebral tissue, have a headache alleviating, relieving fatigue, memory etc. have remarkable efficacy; Can nourish vigour; Can be used for treating altitude sickness; Multiple cancer also there is tangible auxiliary curative effect.
Entomophyte contains rich in protein and 19 seed amino acids, A wide selection of colours and designs, and abundant amount contains a large amount of vitaminss, and wherein: the content of VE is higher than the mushroom class, and VA is higher than 13 times in pork liver, and VB2 is 4 times of genseng, VC is 8 times of mushroom.Contain the necessary trace element of human body more than 17 kinds, the selenium that is called anticancer king that wherein human body is necessary, content is very high.In addition, also contain fat, cordycepic acid, cordycepin, vegeto-alkali, polysaccharide, carbohydrate etc.Entomophyte has following effect: immunity-regulating system, raise immunity; Can be antitumor, have clear and definite inhibition, the effect of killing tumor cell, be used for assisting therapy lung cancer, multiple malignant tumour such as white blood disease; Improve cellular energy, improve the body tolerance to cold, lessen fatigue; Regulate the heart, liver, kidney and respiratory system function, improve the function of internal organ; Regulating blood fat reduces the cholesterol level in the blood, and hemopoietic function improvement can strengthen marrow and generate thrombocyte, red corpuscle and leukocytic ability; Effects such as nourishing, antibiotic, tranquilizing soporific can kidney invigorating and YANG supporting, tonifying lung relievings asthma, hemostasis and phlegm; Impotence due to deficiency of the kidney, waist knee ache etc. also there is good curative effect.
The Radix Astragali contains various trace elements such as saponin, sucrose, polysaccharide, folic acid, 20 multiple amino acids, multivitamin and selenium, zinc, copper.Invigorate the spleen and benefit qi, effects such as tonifying lung is shown admittedly, inducing diuresis to remove edema; Following effect is arranged: strengthen and the adjusting body's immunity, more antibiotic, antiviral; Can strengthen myocardial contraction, excited breathing, anoxia; Can make the cell count showed increased, the cell growth is vigorous, and the life-span prolongs, and is anti-ageing; Can promote organism metabolism, antifatigue; Protect the liver, diuresis, promote serum and hepatic protein renewal, blood sugar regulation content, reducing blood-fat; Can improve the anaemia phenomenon; Protection cardiovascular systems, expansion are preced with artery and are brought high blood pressure down, and reduce thrombosis; Also have effects such as anti-stress, radioprotective in addition.
Snow Lotus Herb contains 10 multiple amino acids, 30 various trace elements such as iron, zinc, potassium, calcium, selenium, clearing heat and detoxicating, wind-damp dispelling, detumescence, pain relieving.Cure mainly snow blindness, toothache, rheumatic arthritis, impotence, gynecopathy, apoplexy, mountain sickness and many chronic diseases such as diseases such as stomach ulcer, hemorrhoid, bronchitis, heart trouble, nasal bleeding and venom.Modern medicine study shows, that the Umbelliferone in the Snow Lotus Herb has is significantly antibiotic, step-down is calm, spasmolysis; Scopoletin has and dispels the wind, anti-inflammatory, pain relieving, eliminates the phlegm and antitumor action, and apigenin has smooth muscle spasmolysis and anti-gastric-ulcer effect; The growth of NSC-757. ability anticancer, clinical in multiple cancers such as treatment mammary cancer, skin carcinoma, white blood disease.
Stigma Croci contains multiple glucoside, various trace elements such as magnesium, zinc, manganese, cobalt, iron, copper, cadmium, and the crocetin that contains in the croceous pistil, crocin and Picrocrocin etc. all have stronger antitumour activity.Promoting blood circulation and removing blood stasis, Azelaic Acid is arranged, the strongly fragrant effect of opening knot of loosing.Control troubled thoughts pent-up, chest diaphragm ruffian is vexed, spits blood, and typhoid fever is gone mad, and is frightened fear in a trance, and the women is through closing postpartum blood stasis stomachache, tumbling and swelling.Can strengthen intracellular oxygen metabolism function, improve the hypoxia-bearing capability of heart; Promote kidney, hepatobiliary function, keep capillary of kidney unobstructed, renal blood flow increasing, effects such as reducing cholesterol and increase metabolism of fat; Immunoregulation effect; Endurance, immunological competence are all had enhancement, but enhancing body endurance plays the operation of adjustment human functional activity of vital energy, the effect of balance human body negative and positive; Antineoplastic action all has stronger restraining effect to white blood disease, ovarian cancer, colorectal carcinoma etc., and with being used of other anticarcinogens, can reduce its toxic side effect.
Cynomorium songaricum contains gallic acid, Protocatechuic Acid, and catechin and salipurpol are the flavonoid glycoside of aglycon, 22 kinds of volatilizations such as palmitinic acid composition, 20 various trace elements such as 15 seed amino acids and calcium, magnesium, zinc, manganese, potassium, sodium, cobalt, chromium, selenium.Cynomorium songaricum is one of medicinal material of the most often using of kidney tonifying, and it can be put down liver kidney tonifying, beneficial intensive culture blood, relax bowel, and is used to treat that insufficiency of kidney-YANG, essence and blood are emptyly lost, waist knee impotence is soft, impotence involuntary emission, the dry constipation of intestines; The Infertility that causes of treatment insufficiency of vital energy and blood, but also strengthening the tendons and bones, supplement calcium; Up-to-date scientific research shows that cynomorium songaricum has very big benefit to function of human body: can promote human body cell regeneration and metabolism, but the enhancing immunity regulatory function; Remove radical; Platelet aggregation-against; Has the effect of carbohydrate cortin appearance; Vitimin supplement and mineral substance; Have tangible anti-cancer, antiviral and delaying senility function.In recent years, all obtained good effect with cynomorium songaricum treatment prostatomegaly and hyperplasia, white blood disease, mellitus, asthma, premature ejaculation.
Herba Cistanches; Contain desert cistanche element, Catalpol, syringin, rhodioside, N.F,USP MANNITOL, Triple Pressed Stearic Acid, β-Gu Zaichun, daucosterol and trimethyl-glycine; And micro-vegeto-alkali and crystallinity neutral substance, also contain various trace elements such as lithium, copper, selenium, strontium, molybdenum, iodine, manganese, iron, zinc, calcium.Kidney-replenishing is arranged, benefiting essence-blood, the effect that relaxes bowel.Be used for impotence due to deficiency of the kidney, wait disease a little less than seminal emission premature ejaculation and the waist knee crymodynia, muscles and bones convulsion.
The fern fiber crops are also claimed Herba Herminii; Contain sucrose, starch, piperylene, protein, tannin, robust fibre, tormentol, fat etc.; Other contains trace elements such as VITAMINs and magnesium, zinc, potassium, calcium, has higher medical treatment and nutritive value, the tonifying spleen of being good for the stomach is arranged, promotes the production of body fluid to quench thirst, the effect of benefiting vital QI for enriching blood, detoxification and promoting urination; The Tibetan medicine is called " tall and erect Lao Sha monk ", and Chang Yiqi is used as medicine.Be used for anaemia after being ill, malnutrition, insufficiency of the spleen diarrhoea, rheumatic arthralgia.
The root of straight ladybell; Contain volatile oil, tonka bean camphor, starch, vegeto-alkali, triterpenic acid, Stigmasterol, each sterol, the root of straight ladybell element, polysaccharide, phosphatide, multiple amino acids and various trace elements etc.; Has following effect: Yin nourishing and lung moistening, reinforcing stomach reg fluid, the ability of holding concurrently clearing away lung-heat, clearing away stomach-heat.The medical literature record cures mainly: the long-pending frightened gas of blood, remove fever and chills, bowl spares, beneficial lung qi; Knot heat evil gas headache, heat symptoms caused by an exopathgen between skin, five viscera settling; A main dizzy pain, beneficial gas, longue meat; The floating wind of peeling skin is controlled Chang Yumian, nourishing the liver gas, a surname's the five internal organs general mood; Qi-restoratives ends frightened tired beneficial cardiopulmonary, apocenosis, detumescence poison; The clearing lung-heat owner of the house where a fire started coughs consumptive lung disease.
Of the present invention have a significant effect: it is fast 1, to cultivate Ganoderma speed, can increase more than 1～1.5 times in 1 month; 2, the Ganoderma color and luster is good, takes on a red color, and is bright-coloured tempting; 3, Ganoderma shapeliness, the Ganoderma that general cultural method is cultivated is in soft state, and is shapeless, and demixing phenomenon is arranged, and needs the hardening of ability more than 1 year, and adopts present method, just can realize that hardening was shaped in 1 month.4, Ganoderma quality better adopts nutritious nutrient solution to cultivate, and it is best in quality.Nutritive ingredient in the above-mentioned prescription of the present invention can guarantee that not only Ganoderma grows fast, and the enrichment of various nutritive ingredients and merging mutually, has also improved the pharmaceutical use of Ganoderma thalline greatly.This shows no matter the present invention is that its benefit is conspicuous to the growth of thalline and eater's health.
Embodiment:
Below in conjunction with embodiment the present invention is done further narration:
Embodiment 1: select mineral water 660 grams, honey 8 grams, Root of Kirilow Rhodiola 6 grams, entomophyte 3 grams; During making, mineral water is placed container, Root of Kirilow Rhodiola, entomophyte are pulverized after cleaning airing, put into mineral water and soaked 24～48 hours, filter residue adds honey again, is the Ganoderma nutrient solution.
Embodiment 2: select mineral water 810 grams, honey 10 grams, Root of Kirilow Rhodiola 10 grams, entomophyte 5 grams; During making, mineral water is placed container, Root of Kirilow Rhodiola, entomophyte are pulverized after cleaning airing, put into mineral water and soaked 24～48 hours, filter residue adds honey again, is the Ganoderma nutrient solution.
Embodiment 3: mineral water 690 grams, honey 8 grams, Root of Kirilow Rhodiola 6 grams, entomophyte 3 grams, the Radix Astragali 8 grams, Snow Lotus Herb 8 grams, Stigma Croci 6 grams; During making, mineral water is placed container, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
Embodiment 4: mineral water 860 grams, honey 10 grams, Root of Kirilow Rhodiola 8 grams, entomophyte 5 grams, the Radix Astragali 10 grams, Snow Lotus Herb 10 grams, Stigma Croci 8 grams; During making, mineral water is placed container, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
Embodiment 5: mineral water 740 grams, honey 8 grams, Root of Kirilow Rhodiola 6 grams, entomophyte 3 grams, the Radix Astragali 8 grams, Snow Lotus Herb 8 grams, Stigma Croci 6 grams, cynomorium songaricum 8 grams, fern fiber crops 8 grams, the root of straight ladybell 8 grams; During making, mineral water is placed container, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
Embodiment 6: mineral water 890 grams, honey 10 grams, Root of Kirilow Rhodiola 8 grams, entomophyte 5 grams, the Radix Astragali 10 grams, Snow Lotus Herb 10 grams, Stigma Croci 8 grams, cynomorium songaricum 10 grams, fern fiber crops 10 grams, the root of straight ladybell 10 grams; During making, mineral water is placed container, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
Among embodiment 5 and the embodiment 6, available Herba Cistanches substitutes cynomorium songaricum, and the component of material is constant.
Container of the present invention can be made by pottery, glass and stainless material.
The material that provides in the various embodiments of the present invention also can be made into the Ganoderma nutritive powder and sell, during making; Material that will be except that honey is worn into fine powder, forms Ganoderma and cultivates the powder base mateiral; Can sell separately, cooperate with honey, mineral water again during use, will cultivate the powder base mateiral and be placed on and soak 24～48 hours in the mineral water; Filter residue adds honey again, forms the Ganoderma nutrient solution.
When utilizing various embodiments of the present invention to cultivate Ganoderma, the Ganoderma bacterial classification is positioned in the nutrient solution, nutrient solution places container, under the condition of 15～35 degree Celsius, and open cultivation 90～120 days, supernatant forms the Ganoderma nutritive medium.
Claims (9)
1. a fast cultivation method for Taisui is positioned over the Ganoderma bacterial classification in the nutrient solution, and nutrient solution places container; It is characterized in that: nutrient solution is to be processed by the raw material of following weight part: 600～950 parts of mineral waters; 6～12 parts of honey, 4～10 parts of Root of Kirilow Rhodiola, 1～7 part of entomophyte; During making, Root of Kirilow Rhodiola, entomophyte are pulverized after cleaning airing, put into mineral water and soaked 24～48 hours, filter residue adds honey again, is the Ganoderma nutrient solution.
2. a fast cultivation method for Taisui is characterized in that: on the raw material basis of the described fast cultivation method for Taisui of claim 1, add 6～12 parts of the Radixs Astragali again, 6～12 parts of Snow Lotus Herb, 4～10 parts of Stigma Crocis; During making, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
3. a fast cultivation method for Taisui is characterized in that: on the raw material basis of the described fast cultivation method for Taisui of claim 2, add 6～12 parts of cynomorium songaricums again, 6～12 parts of fern fiber crops, 6～12 parts of the root of straight ladybell; During making, raw material that will be except that honey is pulverized after cleaning airing, puts into mineral water and soaks 24～48 hours, and filter residue adds honey again, is the Ganoderma nutrient solution.
4. a fast cultivation method for Taisui is characterized in that: in the raw material of the described fast cultivation method for Taisui of claim 3, substitute cynomorium songaricum with Herba Cistanches.
5. according to claim 1 or 2 or 3 described a kind of fast cultivation method for Taisui, it is characterized in that: mineral water refers to the Kun Lun Mountain mineral water, and honey refers to Qaidam matrimony vine honey.
6. according to claim 1 or 2 or 3 described a kind of fast cultivation method for Taisui, it is characterized in that: mineral water refers to be located in the mineral water of promise wood flood; Honey refers to be located in the matrimony vine of the promise wood flood matrimony vine honey when red.
7. according to claim 1 or 2 or 3 described a kind of fast cultivation method for Taisui, it is characterized in that: under the condition of 15～35 degree Celsius, open cultivation 90～120 days forms the Ganoderma nutritive medium.
8. a kind of fast cultivation method for Taisui according to claim 7 is characterized in that: 90% Ganoderma nutritive medium is taken out, after grinding with colloidal mill, obtain supernatant through filtering post precipitation, be the Ganoderma oral liquid.
9. fast cultivation method for Taisui is characterized in that: in claim 1 or the 2 or 3 described a kind of fast cultivation method for Taisui, and raw material that will be except that honey; Wear into fine powder, form Ganoderma and cultivate the powder base mateiral, sell separately; Cooperate with honey, mineral water again during use, will cultivate the powder base mateiral and be placed on and soak 24～48 hours in the mineral water, filter residue; Add honey again, form the Ganoderma nutrient solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100653492A CN101603010B (en) | 2009-06-22 | 2009-06-22 | Fast cultivation method for Taisui |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100653492A CN101603010B (en) | 2009-06-22 | 2009-06-22 | Fast cultivation method for Taisui |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101603010A CN101603010A (en) | 2009-12-16 |
| CN101603010B true CN101603010B (en) | 2012-02-22 |
Family
ID=41468913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100653492A Expired - Fee Related CN101603010B (en) | 2009-06-22 | 2009-06-22 | Fast cultivation method for Taisui |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101603010B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102113448A (en) * | 2010-12-08 | 2011-07-06 | 马兰英 | Rapid cultivation method for high-quality meat lucid ganoderma |
| CN102961604B (en) * | 2012-11-26 | 2014-01-29 | 姜波 | Traditional Chinese medicine preparation for treating viral myocarditis |
| CN103250556A (en) * | 2013-04-16 | 2013-08-21 | 东至林野生态种植中心 | Method for cultivating rhodiola rosea bag material healthcare pleurotus nebrodensis |
| CN103548556B (en) * | 2013-06-04 | 2014-10-29 | 神舟太空产品高科技成果推广中心集团有限公司 | Efficient space-mutagenesis ganoderma lucidum, application thereof and preparation method of capsule preparation of efficient space mutagenesis ganoderma lucidum |
| CN104186197B (en) * | 2014-06-16 | 2016-03-16 | 刘玉勤 | The brilliant breeding method of a kind of meat glossy ganoderma junket film |
| CN106212046A (en) * | 2016-07-28 | 2016-12-14 | 河北岁源饮品有限公司 | A kind of Ganoderma breeding method and the method for manufactured meat Ganoderma water |
| CN110521489A (en) * | 2016-10-14 | 2019-12-03 | 北京京诚生物科技有限公司 | The method for extending living body glossy ganoderma dish garden storage life and improving its preservation quality |
| CN106701595B (en) * | 2016-11-30 | 2020-06-23 | 钟琳 | Method for rapidly domesticating wild meat ganoderma lucidum |
| CN107935643A (en) * | 2017-12-07 | 2018-04-20 | 米西道尔吉 | For cultivating nutrient solution containing cynomorium songaricum nutritional ingredient crop and preparation method thereof |
| CN108112422A (en) * | 2017-12-20 | 2018-06-05 | 河北岁神本草肉灵芝生物科技有限公司 | The breeding method of meat ganoderma lucidum, oral liquid comprising meat ganoderma lucidum and preparation method thereof |
| CN108671089A (en) * | 2018-04-18 | 2018-10-19 | 徐建友 | A kind of meat glossy ganoderma composition and its application in alzheimer's disease |
| CN108401787A (en) * | 2018-05-31 | 2018-08-17 | 吴俊� | A kind of preparation method of Meat-ganoderma composite aethalium |
| CN112970509B (en) * | 2019-12-02 | 2022-09-02 | 河北兴华圣缘生物科技有限公司 | Method for cultivating ganoderma lucidum |
| CN111304118A (en) * | 2020-02-19 | 2020-06-19 | 白山太岁生物科技有限公司 | Culture solution for myxomycete and method for culturing myxomycete |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1660384A (en) * | 2004-02-25 | 2005-08-31 | 高俊山 | Oral liquid of Lingshenhong and preparation method |
| CN1299724C (en) * | 2003-08-19 | 2007-02-14 | 初真文 | Health care products of lucid ganoderma and their preparation |
| CN101278730A (en) * | 2008-04-07 | 2008-10-08 | 孙荣高 | Preparation of ganoderma lucidum rhodiola rosea oral liquid |
-
2009
- 2009-06-22 CN CN2009100653492A patent/CN101603010B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299724C (en) * | 2003-08-19 | 2007-02-14 | 初真文 | Health care products of lucid ganoderma and their preparation |
| CN1660384A (en) * | 2004-02-25 | 2005-08-31 | 高俊山 | Oral liquid of Lingshenhong and preparation method |
| CN101278730A (en) * | 2008-04-07 | 2008-10-08 | 孙荣高 | Preparation of ganoderma lucidum rhodiola rosea oral liquid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101603010A (en) | 2009-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101603010B (en) | Fast cultivation method for Taisui | |
| CN101695376B (en) | Health-care food for preventing diabetes | |
| CN102113448A (en) | Rapid cultivation method for high-quality meat lucid ganoderma | |
| CN101317615B (en) | Silver-thorn tea beverage and preparation method thereof | |
| CN101773595B (en) | Herbal tea for clearing liver and improving eyesight | |
| CN103027151A (en) | Gynostemma penta black tea and preparation method thereof | |
| CN105079465A (en) | Composition capable of lowering blood glucose | |
| CN101711858B (en) | Medicine for treating cancer | |
| CN105233100A (en) | Drink for treating diabetes and preparation method thereof | |
| CN106937741A (en) | A kind of degreasing linseed meal cancer-resisting health slimming method and preparation method thereof | |
| CN101946895B (en) | Functional food taking loach as main material and preparation method thereof | |
| CN103461585B (en) | Qi tonifying and health preserving herbal tea | |
| CN104479964A (en) | Hibiscus esculentus-fungus-algae health wine and preparation method thereof | |
| CN103168813A (en) | Rhodiola rosea fagopyrum tataricum biscuit and preparation method thereof | |
| JP2016077283A (en) | Fermented zen food composition comprising mixture of agricultural product and cereal mycelium, for preventing cancer and diabetes and for enhancing immunity, and production method thereof | |
| CN103922819B (en) | Meat lucid ganoderma nutrient solution preparation method and rapid meat lucid ganoderma culture method | |
| CN1742970A (en) | Fructus citri sarcodactylis tablet | |
| CN109966427A (en) | A kind of fermentation living bacterial liquid and preparation method thereof treated tumour and improve immunity of organisms | |
| CN109730222A (en) | Ferment complex liquid and its health drink | |
| CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
| CN101991110A (en) | Wild ganoderma lucidum food | |
| CN104430720A (en) | Method for making functional biscuits through okra, fungus and algae plant mixtures | |
| CN106701595B (en) | Method for rapidly domesticating wild meat ganoderma lucidum | |
| CN103340991B (en) | Oral liquid for nursing diabetics and preparation method thereof | |
| CN105311375A (en) | Composition for reducing blood lipid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HOU BAOMIN Free format text: FORMER OWNER: JIA YONGCAI Effective date: 20130703 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 816100 HAIXI MONGOL AND TIBETAN AUTONOMOUS PREFECTURE, QINGHAI PROVINCE TO:710000 XI AN, SHAANXI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130703 Address after: 710000, No. 2, unit 4, building seventy-eight, No. 702, No. two, Yanta Road, Yanta District, Shaanxi, Xi'an Patentee after: Hou Baomin Address before: 816100 Qinghai Dulan County Public Security Traffic Police Brigade Patentee before: Jia Yongcai |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120222 |